Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease
Oracle Health and Baylor College of Medicine are joining forces to tackle alcohol-related liver disease (ALD), leveraging AI and real-world data to improve diagnosis and treatment. The collaboration will utilize Oracle's AI data platform, which includes anonymized records of over 120 million patients, while Baylor aims to expand its cohort to more than one million patients.
Seema Verma of Oracle Health emphasized the critical role of early identification in altering disease outcomes. The partnership combines Oracle's data capabilities with Baylor's clinical research expertise, aiming to redefine ALD treatment protocols.